“Prescription vs. Google: Why Doctor-Led Care Matters”
Dr. Caplan’s Clinical Pearl Patients with complex medical conditions often feel overwhelmed by conflicting online advice, leading to frustration and decreased trust in their healthcare providers. In reality, a physician-led care plan is tailored to the…
In the Mix: 8 More Articles — May 04, 2026
This article reviews 25mg CBD gummies, highlighting their interaction with the endocannabinoid system and potential effects on mood, sleep, and pain. The focus on 25mg CBD gummies provides valuable information for clinicians considering patient…
What Are Low-THC Cannabis Products and Why Do Physicians Recommend Lower Potency Formulations? (2026 Doctor’s Guide)
Walk into any Massachusetts dispensary in 2026 and you will find shelves stocked with 30%-THC flower and 1,000 mg concentrate cartridges—products engineered for recreational potency, not therapeutic precision. Yet the most experienced cannabis clinicians…
Clinical Perspective: Running Away Balloon: Patients seeking relief / “Just take random CBD gummies”
Dr. Caplan’s Clinical Pearl Understanding how the endocannabinoid system operates gives patients and doctors far more control over therapy. Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts…
Can You Get a Medical Marijuana Card for Anxiety in Massachusetts? (2026 Doctor’s Guide)
Anxiety disorders affect roughly one in five Massachusetts adults, yet many patients don't realize that debilitating anxiety can legally qualify for a medical cannabis card under state law. The pathwa
Koi CBD Gummies Reviews: A Realistic Assessment for Energy and Metabolic Balance
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDHempDosingSafetyMental HealthAnxietyResearch Clinical Summary This article appears to be a consumer product review of Koi CBD…
“Love at First Dose: The Endocannabinoid System’s Surprising Role”
…
When Conventional Medicine Hits a Wall: Cannabis as Plan B
Dr. Caplan’s Clinical Pearl Most patients who show up in my office didn't start with cannabis. Usually, they've already tried five or six standard prescriptions, dealt with miserable side effects, and hit a wall where their doctors basically…
Why Cannabis Patients Don’t Have to Choose Sides
Dr. Caplan’s Clinical Pearl Here's the beautiful truth that makes this meme obsolete: the plant IS the clinical data. Cannabis contains over 100 cannabinoids and 300+ other compounds that our endocannabinoid system evolved to interact with, which is…
A Cannabinoid Agonist Raised Insulin Sensitivity and a CB1 Blocker Lowered It: Inside an NIH Clamp Study
A National Institute on Aging crossover study used sequential glucose clamps in 21 healthy men to test whether the endocannabinoid system insulin sensitivity link holds up under direct measurement. The cannabinoid agonist nabilone significantly raised…